Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2012

Car Charging Group, Inc. (CCGI) Announces Partnership with S&P MidCap 400 Company to Install EV Charging Stations Nationwide

Posted on January 5, 2012 by MissionIR

In recent news, Car Charging Group told investors that it has secured a partnership with Federal Realty Investment Trust (NYSE: FRT), a $5.6 billion dollar equity real estate investment trust specializing in the ownership, management and redevelopment of high quality … Continue reading →

Posted in Small Cap News | Leave a comment

Car Charging Group, Inc. (CCGI) is “One to Watch”

Posted on January 5, 2012 by MissionIR

Car Charging Group, Inc. is focused on advancing a clean, sustainable environment and an economically strong, energy-independent America. Headquartered in Miami, Florida, the company is one of the nation’s fastest growing providers of EV charging services. Car Charging Group aims … Continue reading →

Posted in Ones to Watch | Leave a comment

Cardium Therapeutics Inc. (CXM) Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea

Posted on January 5, 2012 by Mission IR

Cardium Therapeutics today announced that it has entered into its first international agreement for the commercialization of Excellagen™ in the South Korean market. Cardium entered into a marketing and distribution agreement with BL&H Co. Ltd., an established pharmaceutical company based … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Athersys, Inc. (ATHX) Awarded Patent Protection for MultiStem Product Platform, adding to Current IP Portfolio

Posted on January 4, 2012 by MissionIR

Clinical stage biopharmaceutical company Athersys Inc. today announced it has been granted a patent that covers the company’s proprietary cell therapy product, MultiStem®. MultiStem is an investigational stem cell therapy with demonstrated therapeutic potential to treat a broad range of … Continue reading →

Posted in Small Cap News | Leave a comment

Uranium Energy Corp (UEC) Issues Year-End Shareholder Report

Posted on January 4, 2012 by Mission IR

Uranium Energy today issued a Year-End Shareholder Report. The report from CEO Amir Adnani follows in its complete form: Dear Shareholder, As we begin a new year, I would like to provide for you a status report on the Company’s … Continue reading →

Posted in Uranium Energy Corp. UEC | Leave a comment

Cardium Therapeutics Inc. (CXM) to Present at Upcoming Investor Conferences

Posted on January 4, 2012 by Mission IR

Cardium Therapeutics today announced that it is scheduled to present at the Biotech Showcase 2012 and the 5th Annual OneMedForum Conference in San Francisco. (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) The 2012 Biotech Showcase is being held at the Parc 55 Wyndham in San … Continue reading →

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Navidea Biopharmaceuticals, Inc. (NAVB) is “One to Watch”

Posted on January 3, 2012 by MissionIR

Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corp., is a biopharmaceutical company focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer. The company’s recently announced name change (effective Jan. 5, 2012) reflects the company’s focus on … Continue reading →

Posted in Ones to Watch | Leave a comment

Ampio Pharmaceuticals, Inc. (AMPE) Completes Expanded Patient Enrollment for Study of Anti-inflammatory Candidate

Posted on January 3, 2012 by MissionIR

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities (NMEs), today announced it has completed the expanded patient enrollment phase of its Ampion™ In Knee (AIK) trials in Australia, adding … Continue reading →

Posted in Small Cap News | Leave a comment

VistaGen Therapeutics (VSTA) Makes Good Use of Strategic Partnerships

Posted on January 3, 2012 by MissionIR

VistaGen Therapeutics, a biotechnology company focused on using human stem cell technology for drug rescue and cell therapy, has been proactive in seeking strategic partnerships with other companies and research teams, all in an effort to facilitate the creation of … Continue reading →

Posted in VistaGen Therapeutics Inc. VSTA | Leave a comment

Stock Market Holidays in 2012

Posted on January 3, 2012 by MissionIR

We hope all our readers had a wonderful holiday season. As you know, the stock market was closed a couple days in observation of Christmas and New Year’s Day. Let’s take a look at other days this year the stock … Continue reading →

Posted in Small Cap News | Leave a comment